|
Fusion gene ID: 5644 |
FusionGeneSummary for CAT_CD3D |
Fusion gene summary |
Fusion gene information | Fusion gene name: CAT_CD3D | Fusion gene ID: 5644 | Hgene | Tgene | Gene symbol | CAT | CD3D | Gene ID | 10249 | 915 |
Gene name | glycine-N-acyltransferase | CD3d molecule | |
Synonyms | ACGNAT|CAT|GAT | CD3-DELTA|IMD19|T3D | |
Cytomap | 11q12.1 | 11q23.3 | |
Type of gene | protein-coding | protein-coding | |
Description | glycine N-acyltransferaseAAcHRP-1(CLP)acyl-CoA:glycine N-acyltransferasearalkyl acyl-CoA N-acyltransferasearalkyl acyl-CoA:amino acid N-acyltransferasearalkyl-CoA N-acyltransferasebenzoyl-coenzyme A:glycine N-acyltransferaseglycine N-benzoyltransf | T-cell surface glycoprotein CD3 delta chainCD3 antigen, delta subunitCD3 deltaCD3d antigen, delta polypeptide (TiT3 complex)CD3d molecule, delta (CD3-TCR complex)OKT3, delta chainT-cell receptor T3 delta chain | |
Modification date | 20180519 | 20180523 | |
UniProtAcc | P04040 | P04234 | |
Ensembl transtripts involved in fusion gene | ENST00000241052, ENST00000534710, | ENST00000300692, ENST00000529594, ENST00000392884, | |
Fusion gene scores | * DoF score | 3 X 3 X 3=27 | 2 X 1 X 2=4 |
# samples | 6 | 2 | |
** MAII score | log2(6/27*10)=1.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(2/4*10)=2.32192809488736 | |
Context | PubMed: CAT [Title/Abstract] AND CD3D [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation | Tumor suppressor gene involved fusion gene, retained protein feature but frameshift. DDR (DNA damage repair) gene involved fusion gene, in-frame but not retained their domain. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CAT | GO:0006544 | glycine metabolic process | 22475485 |
Hgene | CAT | GO:1901787 | benzoyl-CoA metabolic process | 22475485 |
Tgene | CD3D | GO:0030217 | T cell differentiation | 2017177 |
Tgene | CD3D | GO:0045944 | positive regulation of transcription by RNA polymerase II | 2017177 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | OV | TCGA-13-0905-01B | CAT | chr11 | 34460626 | + | CD3D | chr11 | 118210209 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000241052 | ENST00000300692 | CAT | chr11 | 34460626 | + | CD3D | chr11 | 118210209 | - |
Frame-shift | ENST00000241052 | ENST00000529594 | CAT | chr11 | 34460626 | + | CD3D | chr11 | 118210209 | - |
Frame-shift | ENST00000241052 | ENST00000392884 | CAT | chr11 | 34460626 | + | CD3D | chr11 | 118210209 | - |
intron-3CDS | ENST00000534710 | ENST00000300692 | CAT | chr11 | 34460626 | + | CD3D | chr11 | 118210209 | - |
intron-3CDS | ENST00000534710 | ENST00000529594 | CAT | chr11 | 34460626 | + | CD3D | chr11 | 118210209 | - |
intron-3CDS | ENST00000534710 | ENST00000392884 | CAT | chr11 | 34460626 | + | CD3D | chr11 | 118210209 | - |
Top |
FusionProtFeatures for CAT_CD3D |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CAT | CD3D |
Occurs in almost all aerobically respiring organisms andserves to protect cells from the toxic effects of hydrogenperoxide. Promotes growth of cells including T-cells, B-cells,myeloid leukemia cells, melanoma cells, mastocytoma cells andnormal and transformed fibroblast cells.{ECO:0000269|PubMed:7882369}. | Part of the TCR-CD3 complex present on T-lymphocyte cellsurface that plays an essential role in adaptive immune response.When antigen presenting cells (APCs) activate T-cell receptor(TCR), TCR-mediated signals are transmitted across the cellmembrane by the CD3 chains CD3D, CD3E, CD3G and CD3Z. All CD3chains contain immunoreceptor tyrosine-based activation motifs(ITAMs) in their cytoplasmic domain. Upon TCR engagement, thesemotifs become phosphorylated by Src family protein tyrosinekinases LCK and FYN, resulting in the activation of downstreamsignaling pathways (PubMed:2470098). In addition of this role ofsignal transduction in T-cell activation, CD3D plays an essentialrole in thymocyte differentiation. Indeed, participates in correctintracellular TCR-CD3 complex assembly and surface expression. Inabsence of a functional TCR-CD3 complex, thymocytes are unable todifferentiate properly. Interacts with CD4 and CD8 and thus servesto establish a functional link between the TCR and coreceptors CD4and CD8, which is needed for activation and positive selection ofCD4 or CD8 T-cells(PubMed:12215456). {ECO:0000269|PubMed:12215456,ECO:0000269|PubMed:12507424, ECO:0000269|PubMed:2470098}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CAT_CD3D |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CAT_CD3D |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
CAT | ABL1, ABL2, CAT, PEX5, USP53, APP, HSD17B4, STIM1, MECP2, EHHADH, KEAP1, ENO1, MOV10, CCDC8, NTRK1, ACAA1, ACE2, ACOX1, AGL, ALDH7A1, ATPIF1, BCAT2, CFL1, CFL2, ENO3, HSPE1, LDHA, LDHB, PGM1, PPA2, SOD1, SOD2, SORD, UFC1, CYCS, FAHD1, FAHD2A, PRDX1, PRDX2, PRDX5, TANGO2, GNAS, JUP, SMARCA4, ACTR3, MCM2, ESR1, CYLD | CD3D | CD8A, CANX, DERL1, AMFR, VCP, ERLIN2, KCNA3, PDIA2, UBQLN1 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CAT_CD3D |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | CAT | P04040 | DB01213 | Fomepizole | Catalase | small molecule | approved|vet_approved |
Tgene | CD3D | P04234 | DB00075 | Muromonab | T-cell surface glycoprotein CD3 delta chain | biotech | approved|investigational |
Tgene | CD3D | P04234 | DB09052 | Blinatumomab | T-cell surface glycoprotein CD3 delta chain | biotech | approved|investigational |
Top |
RelatedDiseases for CAT_CD3D |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CAT | C0268419 | Acatalasia | 5 | CTD_human;ORPHANET |
Hgene | CAT | C0007621 | Neoplastic Cell Transformation | 4 | CTD_human |
Hgene | CAT | C0020538 | Hypertensive disease | 4 | CTD_human |
Hgene | CAT | C0035126 | Reperfusion Injury | 4 | CTD_human |
Hgene | CAT | C0038220 | Status Epilepticus | 4 | CTD_human |
Hgene | CAT | C0011853 | Diabetes Mellitus, Experimental | 3 | CTD_human |
Hgene | CAT | C0027627 | Neoplasm Metastasis | 3 | CTD_human |
Hgene | CAT | C0036572 | Seizures | 3 | CTD_human |
Hgene | CAT | C0001973 | Alcoholic Intoxication, Chronic | 2 | PSYGENET |
Hgene | CAT | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 2 | CTD_human |
Hgene | CAT | C0022661 | Kidney Failure, Chronic | 2 | CTD_human |
Hgene | CAT | C0027540 | Necrosis | 2 | CTD_human |
Hgene | CAT | C0027626 | Neoplasm Invasiveness | 2 | CTD_human |
Hgene | CAT | C1269683 | Major Depressive Disorder | 2 | CTD_human;PSYGENET |
Hgene | CAT | C0003493 | Aortic Diseases | 1 | CTD_human |
Hgene | CAT | C0003873 | Rheumatoid Arthritis | 1 | CTD_human |
Hgene | CAT | C0004045 | Asphyxia Neonatorum | 1 | CTD_human |
Hgene | CAT | C0004096 | Asthma | 1 | CTD_human |
Hgene | CAT | C0004352 | Autistic Disorder | 1 | CTD_human |
Hgene | CAT | C0004943 | Behcet Syndrome | 1 | CTD_human |
Hgene | CAT | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Hgene | CAT | C0007786 | Brain Ischemia | 1 | CTD_human |
Hgene | CAT | C0011849 | Diabetes Mellitus | 1 | CTD_human |
Hgene | CAT | C0011854 | Diabetes Mellitus, Insulin-Dependent | 1 | CTD_human |
Hgene | CAT | C0011882 | Diabetic Neuropathies | 1 | CTD_human |
Hgene | CAT | C0013386 | Dyskinesia, Drug-Induced | 1 | CTD_human |
Hgene | CAT | C0013604 | Edema | 1 | CTD_human |
Hgene | CAT | C0015695 | Fatty Liver | 1 | CTD_human |
Hgene | CAT | C0017638 | Glioma | 1 | CTD_human |
Hgene | CAT | C0018801 | Heart failure | 1 | CTD_human |
Hgene | CAT | C0019158 | Hepatitis | 1 | CTD_human |
Hgene | CAT | C0019189 | Hepatitis, Chronic | 1 | CTD_human |
Hgene | CAT | C0020452 | Hyperemia | 1 | CTD_human |
Hgene | CAT | C0020550 | Hyperthyroidism | 1 | CTD_human |
Hgene | CAT | C0020649 | Hypotension | 1 | CTD_human |
Hgene | CAT | C0022593 | Keratosis | 1 | CTD_human |
Hgene | CAT | C0022650 | Kidney Calculi | 1 | CTD_human |
Hgene | CAT | C0023891 | Liver Cirrhosis, Alcoholic | 1 | CTD_human |
Hgene | CAT | C0024141 | Lupus Erythematosus, Systemic | 1 | CTD_human |
Hgene | CAT | C0024796 | Marfan Syndrome | 1 | CTD_human |
Hgene | CAT | C0025500 | Mesothelioma | 1 | CTD_human |
Hgene | CAT | C0027051 | Myocardial Infarction | 1 | CTD_human |
Hgene | CAT | C0027055 | Myocardial Reperfusion Injury | 1 | CTD_human |
Hgene | CAT | C0029458 | Osteoporosis, Postmenopausal | 1 | CTD_human |
Hgene | CAT | C0032927 | Precancerous Conditions | 1 | CTD_human |
Hgene | CAT | C0033626 | Protein Deficiency | 1 | CTD_human |
Hgene | CAT | C0033860 | Psoriasis | 1 | CTD_human |
Hgene | CAT | C0034063 | Pulmonary Edema | 1 | CTD_human |
Hgene | CAT | C0034065 | Pulmonary Embolism | 1 | CTD_human |
Hgene | CAT | C0034069 | Pulmonary Fibrosis | 1 | CTD_human |
Hgene | CAT | C0038358 | Gastric ulcer | 1 | CTD_human |
Hgene | CAT | C0041408 | Turner Syndrome | 1 | CTD_human |
Hgene | CAT | C0041696 | Unipolar Depression | 1 | PSYGENET |
Hgene | CAT | C0079744 | Diffuse Large B-Cell Lymphoma | 1 | CTD_human |
Hgene | CAT | C0151526 | Premature Birth | 1 | CTD_human |
Hgene | CAT | C0242488 | Acute Lung Injury | 1 | CTD_human |
Hgene | CAT | C0349231 | Phobic anxiety disorder | 1 | CTD_human |
Hgene | CAT | C0376628 | Chromosome Breakage | 1 | CTD_human |
Hgene | CAT | C0878544 | Cardiomyopathies | 1 | CTD_human |
Hgene | CAT | C0993582 | Arthritis, Experimental | 1 | CTD_human |
Hgene | CAT | C1456865 | Ureteral Calculi | 1 | CTD_human |
Hgene | CAT | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Hgene | CAT | C2985290 | Fetal Alcohol Spectrum Disorders | 1 | CTD_human |
Hgene | CAT | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Tgene | CD3D | C0023892 | Biliary cirrhosis | 1 | CTD_human |
Tgene | CD3D | C0023895 | Liver diseases | 1 | CTD_human |
Tgene | CD3D | C0085110 | Severe Combined Immunodeficiency | 1 | CTD_human |
Tgene | CD3D | C0162820 | Dermatitis, Allergic Contact | 1 | CTD_human |
Tgene | CD3D | C0235032 | Neurotoxicity Syndromes | 1 | CTD_human |